Rationale, design and performance of a clinical trial to investigate interferon-gamma (imukin) in the prophylactic treatment of severe burns-related infections
- 1 October 1996
- journal article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 22 (4) , S468-S473
- https://doi.org/10.1007/bf01743726
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Burning the largest immune organBurns, 1995
- Effect of γ-Interferon on the Clinical and Biologic Evolution of Hypertrophic Scars and Dupuytrenʼs DiseasePlastic and Reconstructive Surgery, 1994
- Bacterial translocation after thermal injuryCritical Care Medicine, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Influence of burn-induced lipid—protein on complex on IL1 secretion by PBMC in vitroBurns, 1991
- Effect of Interferon-γ Treatment on the Course of a Burn Wound InfectionJournal of Interferon Research, 1988
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Immunologic Parameters in Burned Patients: Effect of Therapeutic InterventionsPublished by Wolters Kluwer Health ,1986
- Natural killer cell defects resulting from thermal injuryCellular Immunology, 1984
- The abbreviated burn severity indexAnnals of Emergency Medicine, 1982